Topics

AbbVie's Venclyxto pins down CHMP approval for treatment-naive chronic lymphocytic #leukaemia http://bit.ly/2RRZnuq pic.twitter.com/AY68qPXlaO

13:00 EST 3 Feb 2020 | Pharmafile

AbbVie's Venclyxto pins down CHMP approval for treatment-naive chronic lymphocytic http://bit.ly/2RRZnuq 

Original Article: AbbVie's Venclyxto pins down CHMP approval for treatment-naive chronic lymphocytic #leukaemia http://bit.ly/2RRZnuq pic.twitter.com/AY68qPXlaO

NEXT ARTICLE

More From BioPortfolio on "AbbVie's Venclyxto pins down CHMP approval for treatment-naive chronic lymphocytic #leukaemia http://bit.ly/2RRZnuq pic.twitter.com/AY68qPXlaO"

Quick Search

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...